Covis Drug Patent Portfolio
Covis owns 3 orange book drugs protected by 28 US patents Given below is the list of Covis's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10471075 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US11154562 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US11304962 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US9844558 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US9789257 | Needle assisted injection device having reduced trigger force | 11 Feb, 2034 | Active |
| US11446440 | Needle assisted injection device having reduced trigger force | 21 Aug, 2031 | Active |
| US8371292 | Use of ciclesonide for the treatment of respiratory diseases | 01 Feb, 2028 | Active |
| US8021335 | Prefilled syringe jet injector | 04 Oct, 2026 | Active |
| US11446441 | Prefilled syringe injector | 24 Jan, 2026 | Expired |
| US8562564 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9180259 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9533102 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9629959 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US6599498 | Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives | 08 Mar, 2020 | Expired |
| US7553479 | Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof | 08 Mar, 2020 | Expired |
| US7871597 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| US8501158 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| US8591864 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| US8926947 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| USRE44846 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids | 13 May, 2018 | Expired |
| US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds | 13 May, 2018 | Expired |
| US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions | 24 Oct, 2017 | Expired |
| US6006745 | Device for delivering an aerosol | 28 Dec, 2016 | Expired |
| US5775321 | Seal configuration for aerosol canister | 07 Jul, 2015 | Expired |
| US5683677 | Medicinal aerosol formulations | 04 Nov, 2014 | Expired |
| US5605674 | Medicinal aerosol formulations | 25 Feb, 2014 | Expired |
| US6036942 | Seal configuration for aerosol canister | 30 Apr, 2013 | Expired |
Latest Legal Activities on Covis's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Covis.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Apr, 2025 | US11154562 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Apr, 2025 | US9789257 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 17 Apr, 2025 | US8562564 |
| Correspondence Address Change | 12 Dec, 2024 | US11446441 |
| Correspondence Address Change | 12 Dec, 2024 | US8562564 |
| Correspondence Address Change | 12 Dec, 2024 | US9789257 |
| Correspondence Address Change | 12 Dec, 2024 | US9629959 |
| Correspondence Address Change | 12 Dec, 2024 | US9533102 |
| Correspondence Address Change | 12 Dec, 2024 | US11446440 |
| Correspondence Address Change | 12 Dec, 2024 | US9180259 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Oct, 2024 | US9629959 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 31 Jul, 2024 | US8371292 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Jul, 2024 | US9533102 |
|
Expire Patent
Critical
| 18 Dec, 2023 | US10471075 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Jul, 2023 | US10471075 |
Covis Drug Patents' Oppositions Filed in EPO
Covis drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 25, 2014, by Generics [Uk] Ltd (Trading As Mylan). This opposition was filed on patent number EP04766791A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP19150366A | Sep, 2022 | Bandpay & Greuter | Granted and Under Opposition |
| EP06719329A | Oct, 2019 | Bandpay & Greuter | Patent maintained as amended |
| EP04766791A | Sep, 2014 | Generics [UK] Ltd (trading as Mylan) | Patent maintained as amended |
Covis's Family Patents
Covis drugs have patent protection in a total of 17 countries. It has a significant patent presence in the US with 56.3% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Covis Drug List
Given below is the complete list of Covis's drugs and the patents protecting them.
1. Alvesco
Alvesco is protected by 9 patents, out of which 8 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8371292 | Use of ciclesonide for the treatment of respiratory diseases |
01 Feb, 2028
(1 year, 9 months from now)
| Active |
| US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
13 May, 2018
(7 years ago)
| Expired |
| US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds |
13 May, 2018
(7 years ago)
| Expired |
| US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
24 Oct, 2017
(8 years ago)
| Expired |
| US6006745 | Device for delivering an aerosol |
28 Dec, 2016
(9 years ago)
| Expired |
| US5775321 | Seal configuration for aerosol canister |
07 Jul, 2015
(10 years ago)
| Expired |
| US5683677 | Medicinal aerosol formulations |
04 Nov, 2014
(11 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(12 years ago)
| Expired |
| US6036942 | Seal configuration for aerosol canister |
30 Apr, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvesco's drug page
2. Feraheme
Feraheme is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6599498 | Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives |
08 Mar, 2020
(6 years ago)
| Expired |
| US7553479 | Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
08 Mar, 2020
(6 years ago)
| Expired |
| US7871597 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
| US8501158 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
| US8591864 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
| US8926947 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Feraheme's drug page
3. Makena (autoinjector)
Makena (autoinjector) is protected by 13 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10471075 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US11154562 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US11304962 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US9844558 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US9789257 | Needle assisted injection device having reduced trigger force |
11 Feb, 2034
(7 years from now)
| Active |
| US11446440 | Needle assisted injection device having reduced trigger force |
21 Aug, 2031
(5 years from now)
| Active |
| US8021335 | Prefilled syringe jet injector |
04 Oct, 2026
(5 months from now)
| Active |
| US11446441 | Prefilled syringe injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US8562564 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US9180259 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US9533102 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US9629959 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| USRE44846 | Needle assisted jet injector |
10 Aug, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Makena (autoinjector)'s drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List